Allianz Asset Management’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,622
| Closed | -$60.5K | – | 1519 |
|
|
2025
Q1 | $60.5K | Buy |
25,622
+14,044
| +121% | +$33.1K | ﹤0.01% | 1702 |
|
|
2024
Q4 | $32.7K | Sell |
11,578
-8,015
| -41% | -$22.6K | ﹤0.01% | 1666 |
|
|
2024
Q3 | $50.9K | Buy |
19,593
+6,806
| +53% | +$17.7K | ﹤0.01% | 1648 |
|
|
2024
Q2 | $37.9K | Buy |
12,787
+2,394
| +23% | +$7.09K | ﹤0.01% | 1589 |
|
|
2024
Q1 | $47.1K | Buy |
+10,393
| New | +$47.1K | ﹤0.01% | 1624 |
|
|
2022
Q3 | – | Sell |
-10,822,530
| Closed | -$115M | – | 1432 |
|
|
2022
Q2 | $115M | Sell |
10,822,530
-335,515
| -3% | -$3.57M | 0.11% | 202 |
|
|
2022
Q1 | $109M | Sell |
11,158,045
-6,965
| -0.1% | -$67.9K | 0.08% | 255 |
|
|
2021
Q4 | $160M | Sell |
11,165,010
-693,786
| -6% | -$9.92M | 0.11% | 197 |
|
|
2021
Q3 | $238M | Buy |
11,858,796
+1,929,092
| +19% | +$38.7M | 0.18% | 118 |
|
|
2021
Q2 | $218M | Buy |
+9,929,704
| New | +$218M | 0.18% | 111 |
|